Evidence map›Paper›PMID 35740034›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Activation of AMPK/miR-181b Axis Alleviates Endothelial Dysfunction and Vascular Inflammation in Diabetic Mice.

Chak-Kwong Cheng, Wenbin Shang, Jian Liu, Wai-San Cheang, Yu Wang, Li Xiang, Chi-Wai Lau, Jiang-Yun Luo, Chi-Fai Ng, Yu Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. MicroRNA-181 in cardiovascular disease: Emerging biomarkers and therapeutic targets.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Chak-Kwong ChengDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong 999077, China.
Wenbin ShangSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.
Jian LiuDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100871, China.
Wai-San CheangState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Zhuhai 519000, China.ORCID 0000-0002-1152-7997
Yu WangSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.
Li XiangSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.
Chi-Wai LauSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.
Jiang-Yun LuoSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0002-9087-227X
Chi-Fai NgDepartment of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0002-1723-9646
Yu HuangDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong 999077, China.
Li WangDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong 999077, China.
Chinese University of Hong Kong · HKCity University of Hong Kong · HKPeking University · CNUniversity of Macau · MO

Funding

Health and Medical Research Fund 07181286Hong Kong Research Grants Council 14109618Hong Kong Research Grants Council 14164817Hong Kong Research Grants Council C4024-16WHong Kong Research Grants Council SRFS2021-4S04RGC Postdoctoral Fellowship Scheme PDFS 2022/23
6 · The paper itself

Abstract

Hyperglycemia in diabetes mellitus impairs endothelial function and disrupts microRNA (miRNA) profiles in vasculature, increasing the risk of diabetes-associated complications, including coronary artery disease, diabetic retinopathy, and diabetic nephropathy. miR-181b was previously reported to be an anti-inflammatory mediator in vasculature against atherosclerosis. The current study aimed to investigate whether miR-181b ameliorates diabetes-associated endothelial dysfunction, and to identify potential molecular mechanisms and upstream inducer of miR-181b. We found that miR-181b level was decreased in renal arteries of diabetic patients and in advanced glycation end products (AGEs)-treated renal arteries of non-diabetic patients. Transfection of miR-181b mimics improved endothelium-dependent vasodilation in aortas of high fat diet (HFD)/streptozotocin (STZ)-induced diabetic mice, accompanied by suppression of superoxide overproduction and vascular inflammation markers. AMPK activator-induced AMPK activation upregulated miR-181b level in human umbilical vein endothelial cells (HUVECs). Chronic exercise, potentially through increased blood flow, activated AMPK/miR-181b axis in aortas of diabetic mice. Exposure to laminar shear stress upregulated miR-181b expression in HUVECs. Overall, our findings highlight a critical role of AMPK/miR-181b axis and extend the benefits of chronic exercise in counteracting diabetes-associated endothelial dysfunction.

Indexed as

diabetes mellitusendothelial dysfunctionexercisemicroRNAROSshear stressvascular inflammation

Identifiers

PMID35740034
PMCPMC9220246
OpenAlexW4281760709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.